View in EDS

Neutralizing antibody response to SARS-CoV-2 variants, as determined by the MSD multiplex assay, following COVID-19 vaccination in cancer patients.

Saved in:
Bibliographic Details
Title: Neutralizing antibody response to SARS-CoV-2 variants, as determined by the MSD multiplex assay, following COVID-19 vaccination in cancer patients.
Authors: Dukes CW; Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA.; Department of Cancer Epidemiology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA., Whiting J; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA., Mo Q; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA., Cubitt CL; Immune Monitoring Core Facility, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA., Kuter BJ; Department of Infectious Diseases, Moderna, Inc., 200 Technology Square, Cambridge, MA 02139, USA., Leav B; Department of Infectious Diseases, Moderna, Inc., 200 Technology Square, Cambridge, MA 02139, USA., Kennedy K; Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA.; Department of Cancer Epidemiology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA., Rathwell J; Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA.; Department of Cancer Epidemiology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA., Pilon-Thomas S; Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA.; Department of Immunology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA., Giuliano AR; Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA.; Department of Cancer Epidemiology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA.
Source: Vaccine: X [Vaccine X] 2025 Aug; Vol. 25. Date of Electronic Publication: 2025 Jun 20.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101748769 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2590-1362 (Electronic) Linking ISSN: 25901362 NLM ISO Abbreviation: Vaccine X Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42518492
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Neutralizing antibody response to SARS-CoV-2 variants, as determined by the MSD multiplex assay, following COVID-19 vaccination in cancer patients.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Dukes+CW%22">Dukes CW</searchLink>; Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA.; Department of Cancer Epidemiology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA.<br /><searchLink fieldCode="AU" term="%22Whiting+J%22">Whiting J</searchLink>; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA.<br /><searchLink fieldCode="AU" term="%22Mo+Q%22">Mo Q</searchLink>; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA.<br /><searchLink fieldCode="AU" term="%22Cubitt+CL%22">Cubitt CL</searchLink>; Immune Monitoring Core Facility, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA.<br /><searchLink fieldCode="AU" term="%22Kuter+BJ%22">Kuter BJ</searchLink>; Department of Infectious Diseases, Moderna, Inc., 200 Technology Square, Cambridge, MA 02139, USA.<br /><searchLink fieldCode="AU" term="%22Leav+B%22">Leav B</searchLink>; Department of Infectious Diseases, Moderna, Inc., 200 Technology Square, Cambridge, MA 02139, USA.<br /><searchLink fieldCode="AU" term="%22Kennedy+K%22">Kennedy K</searchLink>; Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA.; Department of Cancer Epidemiology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA.<br /><searchLink fieldCode="AU" term="%22Rathwell+J%22">Rathwell J</searchLink>; Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA.; Department of Cancer Epidemiology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA.<br /><searchLink fieldCode="AU" term="%22Pilon-Thomas+S%22">Pilon-Thomas S</searchLink>; Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA.; Department of Immunology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA.<br /><searchLink fieldCode="AU" term="%22Giuliano+AR%22">Giuliano AR</searchLink>; Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA.; Department of Cancer Epidemiology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101748769%22">Vaccine: X</searchLink> [Vaccine X] 2025 Aug; Vol. 25. <i>Date of Electronic Publication: </i>2025 Jun 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Ltd%22">Elsevier Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101748769 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2590-1362 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225901362%22">25901362 </searchLink><i>NLM ISO Abbreviation: </i>Vaccine X <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42518492
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jvacx.2025.100678
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Neutralizing antibody response to SARS-CoV-2 variants, as determined by the MSD multiplex assay, following COVID-19 vaccination in cancer patients.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dukes CW
      – PersonEntity:
          Name:
            NameFull: Whiting J
      – PersonEntity:
          Name:
            NameFull: Mo Q
      – PersonEntity:
          Name:
            NameFull: Cubitt CL
      – PersonEntity:
          Name:
            NameFull: Kuter BJ
      – PersonEntity:
          Name:
            NameFull: Leav B
      – PersonEntity:
          Name:
            NameFull: Kennedy K
      – PersonEntity:
          Name:
            NameFull: Rathwell J
      – PersonEntity:
          Name:
            NameFull: Pilon-Thomas S
      – PersonEntity:
          Name:
            NameFull: Giuliano AR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2025 Aug
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2590-1362
          Numbering:
            – Type: volume
              Value: 25
          Titles:
            – TitleFull: Vaccine: X
              Type: main
ResultId 1